Bold opening: Epilepsy during pregnancy doesn't just complicate a mom's health—it reshapes the entire journey from conception to birth, often raising the stakes for both mother and baby.
The study you provided examines how seizures in pregnant women with epilepsy (WWE) influence perinatal outcomes, and it does so with a nuanced approach that distinguishes seizure types, seizure presence during pregnancy, and the timing of the last preconception seizure. In plain terms, the research asks: does epilepsy itself, and the way it behaves around conception and gestation, change risks like cesarean delivery, fetal growth, and postpartum complications? And if so, which aspects matter most for guiding care?
Key takeaways include: WWE face higher cesarean section (CS) rates and a greater incidence of small-for-gestational-age (SGA) babies compared with healthy pregnancies; seizures during pregnancy are linked to worse perinatal outcomes, and a recent seizure history (within one year before conception) predicts more seizures during pregnancy and certain adverse birth metrics. Notably, the study introduced a novel stratification by last seizure timing before conception (≤1 year vs >1 year), offering a practical clinical lens on pre-pregnancy seizure control and its impact on outcomes.
Background and context
- Epilepsy is relatively common in women of childbearing age, with pregnancy-associated prevalence estimates around 0.3–0.7%. While WWE are considered high-risk, many pregnancies proceed without major complications. Differences in study design, populations, and definitions have led to mixed data on obstetric interventions and adverse outcomes. Ethnicity, geography, and socioeconomic status further modulate risk levels.
- Compared with healthy pregnancies, WWE show higher mortality and adverse perinatal outcomes, including anemia, premature rupture of membranes (PPROM), and postpartum hemorrhage. Careful monitoring, accurate assessment of illness severity, and effective treatment are crucial to mitigate maternal and neonatal risks.
Role of antiseizure medications (ASMs)
- The choice of ASM significantly shapes outcomes. Older-generation drugs (e.g., valproate) carry higher risks of congenital malformations and neurodevelopmental issues. In contrast, newer-generation ASMs (e.g., levetiracetam, lamotrigine) may present lower risk profiles. Thus, understanding each patient’s ASM regimen is essential when evaluating perinatal risk.
Seizure dynamics during pregnancy
- Seizure type and whether seizures occur during pregnancy influence obstetric processes. Some experts advocate optimizing seizure control before conception, given that seizure frequency can vary and potentially alter pregnancy trajectories. Active epilepsy is associated with higher CS rates, driven in part by concerns about seizures during labor and delivery.
Study aims and novelty
- Primary aim: assess the association between maternal epilepsy and adverse perinatal outcomes by comparing WWE with healthy pregnant controls.
- Secondary aim: determine how seizure type, seizure presence during pregnancy, and time since last seizure before conception affect perinatal outcomes.
- Novel contribution: stratification of WWE by last preconception seizure timing (≤1 year vs >1 year), offering new clinical insight into pre-pregnancy seizure control and its relationship with perinatal outcomes.
Methods in brief
- Design: Retrospective, single-center study at Necmettin Erbakan University Medical Faculty Hospital, 2016–2022.
- Participants: 100 WWE and 200 low-risk pregnant controls. Exclusions included major fetal anomalies and non-clinic births to reduce confounding.
- Data: Extracted from electronic medical records across outpatient, delivery, and operating room settings. Seizure data encompassed patient-reported events and hospital-verified episodes. Subgroups included focal (nongeneralized) vs generalized seizures and presence/absence of seizures during pregnancy; last preconception seizure timing was categorized as ≤1 year or >1 year before conception.
- Outcomes: Rates of small for gestational age (SGA), preterm birth (PTB), PPROM, gestational diabetes, placental abruption, uterine atony, preeclampsia, cesarean delivery, postpartum hemorrhage, Apgar scores, transfusion, and fetal death.
Key findings
- WWE showed higher cesarean rates (71%) than controls (55.5%), and lower newborn weight percentiles with more SGA infants (28% vs 12%). WWE also had longer hospital stays.
- Seizures during pregnancy occurred in 45% of WWE; most were managed with a single ASM, and a majority did not change ASM during pregnancy.
- When comparing WWE with and without seizures during pregnancy, those with seizures had a markedly higher CS rate (91.1% vs 54.5%). Seizure history within the year before conception correlated with more seizures during pregnancy.
- Fetal outcomes (birth weight, gestational age at birth, Apgar scores) and maternal outcomes (atony, preeclampsia, PPROM, placental abruption) did not differ significantly between generalized vs nongeneralized seizures, except for a lower mean birth weight percentile in generalized seizures.
- Preconception seizure timing mattered: WWE with seizures within 1 year before pregnancy delivered earlier and with lower birth weights than those whose last seizure occurred more than a year before conception. Cesarean rates were higher in the ≤1-year group.
- ASM content (drug type or dosage) did not show a statistically significant association with seizure presence during pregnancy in this dataset.
Discussion and interpretation
- The study reinforces that WWE face elevated risks for CS and SGA babies, and that seizure activity—especially near conception or during pregnancy—can influence perinatal outcomes. The authors note longer hospital stays in WWE, which may reflect heightened monitoring and management complexity in tertiary care settings.
- Comparisons to other research show mixed results regarding maternal mortality and other adverse outcomes, likely influenced by study designs, inclusion criteria (e.g., exclusion of anomalies, multiple pregnancies), and regional practice patterns—such as overall higher CS rates in Turkey.
- The shift from older to newer ASMs appears promising in broader literature, with newer drugs offering potentially safer profiles, but data remain imperfect and context-dependent. The study acknowledges limitations, including its retrospective nature, single-center scope, and incomplete ASM-level data, which restrain deeper causal inferences about drug effects or seizure severity.
Strengths and limitations
- Strengths: Detailed subgroup analyses by seizure type, seizure presence during pregnancy, and preconception seizure timing; comprehensive capture of fetal and maternal outcomes within a well-documented cohort.
- Limitations: Retrospective, single-center design limits generalizability; unable to parse ASM levels or seizure severity in depth; potential underreporting of mild or unrecorded seizures; exclusion of anomalies reduces broader applicability; lack of long-term neonatal outcome data.
Clinical implications
- The presence of seizures before conception emerges as a strong predictor of seizures during pregnancy and associated obstetric risks. This underscores the importance of preconception counseling and sustained seizure control prior to attempting pregnancy.
- Although seizure presence during pregnancy is linked to adverse perinatal outcomes, a cesarean decision should not be based on epilepsy alone. Individualized care, including multidisciplinary coordination among obstetrics, neurology, and maternal-fetal medicine, is essential to balance maternal safety with neonatal well-being.
- The study supports ongoing monitoring and ASM optimization during pregnancy, with attention to evolving evidence about safer, newer-generation medications.
Bottom line
- Pregnant WWE encounter higher rates of cesarean delivery and SGA infants compared with healthy pregnancies, and active seizures during pregnancy portend worse perinatal outcomes. Pre-pregnancy seizure control—particularly maintaining a seizure-free interval of at least one year before conception—appears to be a meaningful target for improving outcomes. While this work adds valuable nuances, especially around the timing of last seizures, its retrospective, single-center nature calls for prospective, multicenter research with ASM-level data to guide best practices more definitively.
Discussion prompt
- Do you think focusing on a one-year preconception seizure-free window should become a standard goal for WWE planning pregnancy, even if it means delaying conception for some patients? What ethical or practical considerations would you weigh in making such recommendations?
